Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization
The DOI matches its Crossref record.
Abstract
We have generated a number of mAb against various epitopes on the external envelope glycoprotein, gp46, of human T cell leukemia virus type I (HTLV-I) from a WKA rat immunized with a recombinant vaccinia virus containing the HTLV-I env gene. Among these mAb, one group of mAb, represented by a mAb designated LAT-27, could neutralize the infectivity of HTLV-I, as determined by a HTLV-I-mediated cell fusion inhibition assay. LAT-27 also interfered with transformation of normal T lymphocytes by HTLV-I in vitro. An antibody-binding assay using overlapping synthetic oligopeptides showed that LAT-27 bound specifically to 10-mer peptides that contained the gp46 amino acid sequence 191-196 (Leu-Pro-His-Ser-Asn-Leu). Antibodies from HTLV-I+ humans interfered with the binding of LAT-27 to gp46 Ag. Sera from rabbits immunized with a LAT-27-reactive peptide, 190-199, conjugated with OVA, but not sera from OVA-immunized rabbits, reacted with gp46 Ag and neutralized infectivity of HTLV-I. These results show that the HTLV-I neutralization epitope recognized by LAT-27 locates to the gp46 amino acids 191-196, and that immunization with a peptide containing the LAT-27 epitope can elicit an HTLV-I neutralizing antibody response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASES
Uchiyama, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.15 · Cited by 392
Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection
Flier, J. S., Underhill, L. H., Hollsberg, P., & Hafler, D. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281608 · Cited by 318
An HTLV-I Vaccine: Why, How, for Whom?
DE THÉ, G., & BOMFORD, R. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.381 · Cited by 272
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
Hoshino, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00222 · Cited by 58
“The rat monoclonal antibody LAT-27 recognizes a peptide epitope (amino acids 191–196) and potently neutralizes cell-free HTLV-1 infection and inhibits HTLV-1-induced syncytia formation (Tanaka et al., 1991).”
BackgroundCoskun, A. K., & Sutton, R. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4150-4158.2005 · Cited by 48
Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Kuo, C.-W. S., & Brighty, D. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82390-0 · Cited by 8
“, 1997), anti-Env antibodies (Baba et al., 1993; Blanchard et al., 1999; Burton et al., 2004, 2005; Desgranges et al., 1994; Kuroki et al., 1992; Palker et al., 1992; Shida et al., 1987; Tanaka et al., 1991), recombinant competitive ligands (Deen et al.”
Background
Metadata
- Authors
- Tanaka, Y., Zeng, L., Shiraki, H., Shida, H., & Tozawa, H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-07-01
- Volume
- 147
- Issue
- 1
- Pages
- 354-360
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1591641721
- Cited by
- 137
- References
- 0
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.